
“API profit beast with DII conviction amid FII fade.”
No clear market view today
The signals we track (volume, delivery, price trend, deals, breadth and flows) aren't aligned for NEULANDLABtoday. That isn't bearish, just inconclusive.
India-specific risk checks.
Four fundamentals lenses on the company itself: valuation, growth, returns & margins, and financial health, judged against the stock's sector. A separate read from the Market Setup above.
Valuations look stretched
₹1,000 invested here buys about ₹16 of annual profit. A cheaper stock would buy more.
Strong revenue and profit growth
Excellent returns and margins
Strong balance sheet
Data as of 19 Jun 2026, 9:31 pm